PATENT CLAIM ANALYSIS

Application Number: 15780904
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "546000"]

Abstract:
The invention relates to a composition for induction of activity of a nuclear receptor PPARy in a subject in need thereof, which comprises at least one of benzoate or a synergistic combination of benzoate and phenylacetate in association with a pharmaceutical carrier.

Claim (Index 8):
The method of  claim 5 , wherein said inducing activity of a nuclear receptor PPAR\u03b3 improves symptoms of at least one of inflammation, pain, autoimmune diseases, neurodegenerative inflammatory diseases, cancer, diabetes type 2, and other metabolic diseases to replace PPAR\u03b3 agonists.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.29412
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14122611', '16074750', '12786290', '11965425', '15307119']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7707482364395498
- 35 USC 102 Novelty (BERT): 0.5414388466246102
- Combined Prediction Score: 0.7478172974580558
- Mean Citation Score: 333.7134240000001
- Max Citation Score: 366.92035
- Similarity Product: 218.6187270709396

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test